Androgenetic Alopecia: Just a Cosmetic Defect or a Biomarker and Risk Factor for Systemic Diseases? Literature Review

July 2025 in “ Journal of Education Health and Sport ”

Dawid Suwała, Natalia Pokrywka, M Polak, Klaudia Koryszko, Paulina Hetnar, Magdalena Tomala, Sebastian Kiper, Milena Fortuna, Sławomir Toczek, Katarzyna Jastrowicz-Chęć

androgenetic alopecia cardiovascular diseases metabolic disorders endocrine disorders prostate cancer scalp cancer mental health AGA

TLDR Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

The literature review suggests that androgenetic alopecia (AGA) is not just a cosmetic issue but may also be a biomarker and risk factor for systemic diseases. Studies show that individuals with AGA are more likely to develop cardiovascular diseases, metabolic or endocrine disorders, and possibly prostate and scalp cancers. AGA also has a negative impact on mental health. The review emphasizes the need for an interdisciplinary approach for early detection and prevention of diseases and calls for further research to understand the mechanisms linking AGA to systemic conditions and to create screening protocols.

View this study on apcz.umk.pl →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

in Research 865 upvotes 8 months ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 11 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community He used Dutasteride for 20 years. Interview

in Treatment 112 upvotes 8 months ago

Dutasteride has been used for 20 years with some hair thickness improvement but no dramatic regrowth. The user also experimented with minoxidil, tretinoin, and peptides like BPC 157 for potential benefits in hair density and quality.

community Everyone is ignoring that plasma finasteride levels are 100x lower with topical compared to oral.

in Research/Science 140 upvotes 1 year ago

Topical finasteride results in plasma levels 100 times lower than oral finasteride, potentially reducing systemic side effects. Users report similar efficacy with fewer side effects, suggesting a preference for topical application.

community PYRILUTAMIDE KX-826 experience

in Research/Science 99 upvotes 2 years ago

A user's experience with the hair loss treatment Pyrilutamide KX-826, which has resulted in some side effects and shedding. The conversation also includes advice for baseline pictures and trying treatments for at least 6 months.

community Update on my progress after 10,5 months

in Progress Pictures 147 upvotes 5 months ago

The user has been using a combination of oral finasteride, oral dutasteride, topical and oral minoxidil, microneedling, and keto shampoo for hair loss, experiencing significant shedding recently. Suggestions include simplifying the regimen by dropping finasteride and topical minoxidil, and possibly adding RU58841, while others advise maintaining the current approach for consistent results.

Similar Research

5 / 1000+ results

research Appearance and Internal Aging

September 2016 in “Springer eBooks”

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

research Impaired Metabolic Effects of Metformin in Men with Early-Onset Androgenic Alopecia

4 citations, December 2021 in “Pharmacological Reports”

Metformin is less effective in men with early-onset hair loss.

Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?

research Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?

9 citations, February 2020 in “International Journal of Endocrinology”

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

research COVID-19 and Endocrine and Metabolic Diseases: An Updated Statement from the European Society of Endocrinology

68 citations, May 2021 in “Endocrine”

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

research Basic Mechanisms of SARS-CoV-2 Infection: Implications for Endocrine Systems

14 citations, July 2021 in “Reviews in endocrine and metabolic disorders”

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.